COLOGNE, Germany--(BUSINESS WIRE)--Axiogenesis AG and iPS Academia Japan Inc. (Kyoto, Japan) announced that they have executed a non-exclusive agreement with iPS Academia (Kyoto, Japan) through which ...
The United States Patent and Trademark Office (USPTO) has granted patent for Axiogenesis AG for the invention of its in vitro assay to screen pharmaceutical drug candidates for effectiveness and ...
Induced pluripotent stem cell (iPSC) specialist Axiogenesis AG has partnered with ion channel CRO Metrion Biosciences to develop human iPSC-derived cardiomyocytes and neurons for drug discovery ...
GOSSELIES,Belgium & COLOGNE, Germany & LEIDEN, Netherlands & PHILADELPHIA--(BUSINESS WIRE)--Ncardia (www.ncardia.com) has been established following the merger of Pluriomics and Axiogenesis. The ...
Axiogenesis AG and Metrion Biosciences Ltd have signed a collaboration agreement to validate, optimise and commercialise iPSC-derived cell based assays to facilitate drug discovery and more accurately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback